G1 Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GTHX and other ETFs, options, and stocks.

About GTHX

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. 

CEO
Jack Bailey
CEOJack Bailey
Employees
148
Employees148
Headquarters
Research Triangle Park, North Carolina
HeadquartersResearch Triangle Park, North Carolina
Founded
2008
Founded2008
Employees
148
Employees148

GTHX Key Statistics

Market cap
533.05M
Market cap533.05M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.36M
Average volume1.36M
High today
$12.96
High today$12.96
Low today
$11.96
Low today$11.96
Open price
$12.35
Open price$12.35
Volume
985.07K
Volume985.07K
52 Week high
$17.49
52 Week high$17.49
52 Week low
$3.84
52 Week low$3.84

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

GTHX Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.